Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Management of bone disease in myeloma patients: zoledronic acid or denosumab?]Masahiro Abe, Hirokazu Miki, Shingen Nakamura[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 15, 2016
[Multiple myeloma]Masahiro Abe, Hirokazu Miki, Shingen NakamuraThe Journal of Medical Investigation : JMI|April 23, 2025
Hematology in community medical careShingen Nakamura, Yusaku Maeda, Taiki Hori, et al.Journal of Bone and Mineral Metabolism|March 1, 2023
Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agentsJumpei Teramachi, Hirokazu Miki, Shingen Nakamura, et al.Infection Control and Hospital Epidemiology|October 19, 2019
Pseudo-outbreak of <i>Mycobacterium chimaera</i> through aerators of hand-washing machines at a hematopoietic stem cell transplantation centerShingen Nakamura, Momoyo Azuma, Masami Sato, et al.Hematological Oncology|March 29, 2025
Detection of Hematological Malignancies Using N-NOSE (Nematode-NOSE)Shingen Nakamura, Hideyuki Hatakeyama, Sumiko Yoshida, et al.International Journal of Hematology|September 4, 2020
Involvement of oral bacteria and oral immunity as risk factors for chemotherapy-induced fever with neutropenia in patients with hematological cancerYuka Sogawa, Makoto Fukui, Shingen Nakamura, et al.Internal Medicine (Tokyo, Japan)|August 4, 2017
Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena CavaShingen Nakamura, Kumiko Kagawa, Ryohei Sumitani, et al.The Journal of Medical Investigation : JMI|April 23, 2025
Congenital hypofibrinogenemia with a novel mutation BβCys76PheMotoki Sugasaki, Shingen Nakamura, Shinpei Arai, et al.Clinical Pharmacology in Drug Development|January 28, 2023
Clinical Impact of Antipolyethylene Glycol (PEG) Antibody in Hematological Patients Administered PEGylated-Granulocyte Colony-Stimulating FactorNaoto Okada, Shimizu Taro, Hidenori Ando, et al.Pageof 9